ORIC-944 | MedChemExpress (MCE)
ORIC-944 is a selective, orally active, allosteric inhibitor targeting the EED subunit of polycomb repressive complex 2 (PRC2). ORIC-944 is synergistic with androgen receptor pathway inhibitors (ARPIs) for the study of metastatic prostate cancer.
| Trivial name | ORIC-944 |
| Catalog Number | HY-158102 |
| Research Area | Cancer |
| CAS# | 2369769-29-7 |
| Purity | ≥98.0% |
| SMILES | CC1=C(C=CC(CN(C)C)=C1)C2=CN=C(N3C=C(N=C23)C#N)NCC4=C(C=CC5=C4CCO5)F |
| Size | 25 mg |
| Supplier Page | https://www.medchemexpress.com/oric-944.html |